Trexquant Investment LP Ab Cellera Biologics Inc. Transaction History

Trexquant Investment LP

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	BUY	$4.6 - $7.95 $1.03 Million - $1.78 Million	223,430 Added 458.52%	272,158 $1.25 Million
Q2 2023 Aug 11, 2023	BUY	$5.66 - $7.59 $275,800 - $369,845	48,728 New	48,728 $314,000
Q4 2022 Feb 13, 2023	BUY	$9.48 - $14.52 $927,542 - $1.42 Million	97,842 New	97,842 $991,000
Q2 2022 Aug 11, 2022	SELL	$5.72 - $10.65 $326,085 - $607,135	-57,008 Reduced 24.69%	173,864 $1.85 Million
Q1 2022 May 13, 2022	BUY	$7.46 - $14.14 $1.3 Million - $2.46 Million	173,765 Added 304.28%	230,872 $2.25 Million
Q4 2021 Feb 14, 2022	BUY	$12.99 - $17.73 $741,819 - $1.01 Million	57,107 New	57,107 $817,000
Q3 2021 Nov 12, 2021	SELL	$14.85 - $21.34 $164,864 - $236,916	-11,102 Closed	0 $0
Q2 2021 Aug 12, 2021	BUY	$20.19 - $34.17 $224,149 - $379,355	11,102 New	11,102 $244,000

155

109M

153K

194K

Ticker ABCL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 285,139,008
Market Cap $807M
Description
AbCellera Biologics Inc. develops antibody discovery platform. Its full-stack, artificial intelligence-powered antibody discovery platform searches and analyzes the database of natural immune systems to find antibodies that could be developed as drugs. As of December 31, 2021, the company had 156 discovery programs that are either completed, in ...

Get notified when there are updates to the investment portfolio of Trexquant Investment LP, based on Form 13F filings with the SEC.

Stay updated on Trexquant Investment LP with notifications on news.